Multibagger stock rises 4.5% after Q2 results 2026 - Up 500% in 5 years; will rally continue? Experts' views, target, SL

What happened

Sakar Healthcare shares opened at Rs.943.50 on 26 October, compared with the previous close of Rs.885, after Q2 results for the quarter ending 30 September 2026. Net profit rose 149% year on year to Rs.11.30 crore and revenue grew 51.9% to Rs.87.41 crore.

Confirmed

Global impact / market context

Faster profit growth than revenue growth means the company kept more profit from each sale, which means its profit per sale improved. Investors often pay more for shares when earnings rise quickly, so the stock's 500% five-year gain may attract attention even after a weak past month.

Analyst inference

The stock fell 17.81% over the past month but gained 1.12% in the past week, so results may have eased recent selling pressure. Its 129.42% year-to-date gain means the shares already price in strong expectations, leaving less room for disappointment.

Analyst inference

What to watch

1. Watch whether revenue growth of 51.9% and profit after tax margin of 13%, which means profit kept from each sale, hold up in coming quarters now that these results are public. Confirmed
2. Experts cited in the article may suggest a target price and a stop loss, which means a set price at which an investor sells to limit losses, so compare these with current levels. Proposed
3. Watch whether the stock holds above its recent low near Rs.949.80, because a break lower could signal that the results boost faded and that sellers remain in control. Analyst inference

Evidence

• Original source link unavailable